Yi-Hua Sheng

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

National Taiwan University(Current)

National Taiwan University Hospital

Yi-Hua Sheng is an author at National Taiwan University specializing in topoisomerase ii inhibitors, cell-nanoparticle interactions, and anticancer activity.

Publications per year

2019–2022

Publications

Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis

Hui‐Teng Cheng, Hsi‐Chien Huang, Tsung‐Ying Lee et al. · Journal of Controlled Release · 2022 · 31 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems

Jo‐Fan Chang, Jui‐Ling Hsu, Yi-Hua Sheng et al. · Frontiers in Oncology · 2019 · 23 citations · Full text

Medicine, Oncology, Pharmacology +15

1–2 of 2